Massachusetts Financial Services’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-515,839
| Closed | -$305K | – | 885 |
|
|
2024
Q4 | $305K | Sell |
515,839
-53,493
| -9% | -$31.6K | ﹤0.01% | 858 |
|
|
2024
Q3 | $1M | Buy |
569,332
+28,133
| +5% | +$49.5K | ﹤0.01% | 796 |
|
|
2024
Q2 | $741K | Buy |
541,199
+14,737
| +3% | +$20.2K | ﹤0.01% | 811 |
|
|
2024
Q1 | $1.81M | Sell |
526,462
-2,694
| -0.5% | -$9.27K | ﹤0.01% | 739 |
|
|
2023
Q4 | $1.3M | Buy |
529,156
+489
| +0.1% | +$1.2K | ﹤0.01% | 751 |
|
|
2023
Q3 | $899K | Sell |
528,667
-227,686
| -30% | -$387K | ﹤0.01% | 771 |
|
|
2023
Q2 | $2.27M | Sell |
756,353
-10,729
| -1% | -$32.2K | ﹤0.01% | 694 |
|
|
2023
Q1 | $2.06M | Buy |
767,082
+110,800
| +17% | +$297K | ﹤0.01% | 711 |
|
|
2022
Q4 | $5.41M | Buy |
656,282
+124,495
| +23% | +$1.03M | ﹤0.01% | 646 |
|
|
2022
Q3 | $4.1M | Buy |
531,787
+36,019
| +7% | +$277K | ﹤0.01% | 662 |
|
|
2022
Q2 | $1.41M | Sell |
495,768
-3,723
| -0.7% | -$10.6K | ﹤0.01% | 753 |
|
|
2022
Q1 | $2.5M | Buy |
499,491
+13,801
| +3% | +$69K | ﹤0.01% | 735 |
|
|
2021
Q4 | $9.53M | Sell |
485,690
-3,575
| -0.7% | -$70.2K | ﹤0.01% | 663 |
|
|
2021
Q3 | $14.4M | Buy |
489,265
+66,242
| +16% | +$1.95M | ﹤0.01% | 645 |
|
|
2021
Q2 | $17.9M | Sell |
423,023
-1,214
| -0.3% | -$51.5K | 0.01% | 627 |
|
|
2021
Q1 | $21.6M | Sell |
424,237
-75,634
| -15% | -$3.85M | 0.01% | 597 |
|
|
2020
Q4 | $17M | Buy |
+499,871
| New | +$17M | 0.01% | 608 |
|